Literature DB >> 29432867

Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.

Shin-Ichi Yokota1, Hiroshi Hakamada2, Soh Yamamoto2, Toyotaka Sato2, Tsukasa Shiraishi2, Masaaki Shinagawa3, Satoshi Takahashi4.   

Abstract

Pseudomonas aeruginosa is an important etiological agent of opportunistic infections. Injectable colistin is available as a last-line treatment option for multidrug-resistant P. aeruginosa infections. When cells were inoculated at a high number, colistin-susceptible P. aeruginosa grew on agar medium containing colistin at a concentration 10-fold higher than the minimum inhibitory concentration without acquiring colistin resistance. This study examined the responsible mechanism for growth in the presence of a high concentration of colistin. Cell wash fluid derived from P. aeruginosa efficiently reduced colistin antimicrobial activity. This reduction was mediated by lipopolysaccharide (LPS) in the wash fluid. Extracellular LPS inhibited colistin activity more effectively than cell-bound LPS in fixed cells. Cell wash fluids from Escherichia coli and Acinetobacter baumannii also reduced colistin activity; however, they were less potent than those from P. aeruginosa. The amount of LPS in cell wash fluid from P. aeruginosa was approximately 10-fold higher than that in fluid from E. coli or A. baumannii. In conclusion, cell-free LPS derived from bacterial cells inhibited the antimicrobial activity of colistin, and this effect was greatest for P. aeruginosa. Thus, large amounts of broken and dead cells of P. aeruginosa at infection foci will reduce the effectiveness of colistin, even against cells that have not yet acquired resistance.
Copyright © 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Colistin; Escherichia coli; Lipopolysaccharide; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2018        PMID: 29432867     DOI: 10.1016/j.ijantimicag.2018.02.004

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  A New Pharmacokinetic-Pharmacodynamic Model To Characterize the Inoculum Effect of Acinetobacter baumannii on Polymyxin B In Vitro.

Authors:  Grace Akrong; Alexia Chauzy; Vincent Aranzana-Climent; Mathilde Lacroix; Luc Deroche; Laure Prouvensier; Julien M Buyck; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

2.  Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill Pseudomonas aeruginosa.

Authors:  Esther Sweeney; Akshay Sabnis; Andrew M Edwards; Freya Harrison
Journal:  Microbiology (Reading)       Date:  2020-12       Impact factor: 2.777

3.  In Vivo Evaluation of ECP Peptide Analogues for the Treatment of Acinetobacter baumannii Infection.

Authors:  Jiarui Li; Guillem Prats-Ejarque; Marc Torrent; David Andreu; Klaus Brandenburg; Pablo Fernández-Millán; Ester Boix
Journal:  Biomedicines       Date:  2022-02-05

Review 4.  The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology.

Authors:  Steven M Huszczynski; Joseph S Lam; Cezar M Khursigara
Journal:  Pathogens       Date:  2019-12-19

Review 5.  Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.

Authors:  Elizabeth V K Ledger; Akshay Sabnis; Andrew M Edwards
Journal:  Microbiology (Reading)       Date:  2022-02       Impact factor: 2.777

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.